3 Promising Oncology Stocks To Consider Adding To Your Portfolio
June 14, 2021 at 01:31 AM EDT
With tech integration and DNA sequencing increasing the efficacy of potential cancer drugs in the pipeline, we believe biotech names AstraZeneca, Amgen and Incyte are worth adding to a portfolio.
